SCHEMBL656139

SCHEMBL656139

O=C(/C=C/c1ccc(Cl)cc1Cl)c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.70
▸ ALDH1A1 P00352 3/20 0.70
▸ KDM4E B2RXH2 2/20 0.70
▸ PKM P14618 1/20 0.70
▸ PTPN5 P54829 1/20 0.62
▸ MAOB P27338 3/20 0.61
▸ MAPT P10636 6/20 0.61
▸ KMT2A Q03164 3/20 0.61
▸ L3MBTL1 Q9Y468 2/20 0.61
▸ CYP1B1 Q16678 1/20 0.57
▸ TYR P14679 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ HSP90AA1 P07900 1/20 0.56
▸ GAA P10253 1/20 0.56
▸ GRM5 P41594 1/20 0.54
▸ NPC1 O15118 2/20 0.52
▸ RAB9A P51151 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ POLB P06746 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL656140 1.00 LMNA (0.70) LMNAALDH1A1KDM4EPKMPTPN5
SCHEMBL1225556 0.90 LMNA (0.65) LMNAALDH1A1KDM4EPKMPTPN5
SCHEMBL1225557 0.90 LMNA (0.65) LMNAALDH1A1KDM4EPKMPTPN5
Bromide SCHEMBL11834530 0.89 LMNA (0.63) LMNAALDH1A1KDM4EPKMPTPN5
Bromide SCHEMBL11834524 0.89 LMNA (0.63) LMNAALDH1A1KDM4EPKMPTPN5
SCHEMBL14290443 0.86 CHRNA7 (0.67) LMNAALDH1A1KDM4EPKMPTPN5
SCHEMBL21647110 0.86 TYR (0.72) LMNAALDH1A1KDM4EPKMMAOB
SCHEMBL21647126 0.86 TYR (0.72) LMNAALDH1A1KDM4EPKMMAOB
SCHEMBL29837044 0.86 TYR (0.72) LMNAALDH1A1KDM4EPKMMAOB
SCHEMBL28068228 0.86 TYR (0.72) LMNAALDH1A1KDM4EPKMMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110204474-B Method for synthesizing tetra-substituted NH-pyrrole compound 浙江工业大学 2020-10-30 — — CN disclosed
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 — — EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 — — US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 — — US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 — — EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 — — WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB LMNA 3119/4885ALDH1A1 4784/4885KDM4E 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback